DUBLIN, Jan. 4, 2021 /PRNewswire/ -- The "Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Centrifuge), Cell Type (Human, Animal), Cell Source (Bone Marrow, Adipose), Technique (Filtration), Application (Cancer, IVD), End-User (Hospitals, Biotechnology) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global cell isolation market is expected to reach USD 14,995.98 million by 2025 from USD 6894.32 million in 2020, at a CAGR of 16.8% during the forecast period.
Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects and the rising prevalence of diseases such as cancer. With the rising focus on the development of personalized medicine, the number of personalized medications available in the market has steadily increased over the last decade, and this trend is expected to continue in the coming years.
The consumables accounted for the highest growth rate in the cell isolation market, by product during the forecast period
Based on the product, the cell isolation market is segmented into consumables and instruments. The consumables segment accounted for the largest share in the cell isolation market in the forecasted period. The increasing investments by companies to develop technologically advanced products as well as the repetitive use of consumables as compared to instruments are the major factors driving the growth of this segment.
Human cells segment accounted for the highest CAGR
Based on cell type, the cell isolation market is segmented into human cells and animal cells. The human cells segment accounted for the largest share of the global cell isolation market in the forecasted period. The increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the high and growing incidence of diseases such as cancer are the major factors driving this segment's growth.
Biotechnology and biopharmaceutical companies segment accounted for the highest CAGR
The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally, are the major factors driving this segment's growth.
Asia Pacific: The fastest-growing region cell isolation market
The global cell isolation market is segmented into North America, Europe, Asia Pacific, and the Rest of the world. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the expansion by key market players in emerging Asian countries and the increasing trend of pharmaceutical outsourcing to Asian countries like India and China are driving the growth of the cell isolation market in this region.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights 4.1 Cell Isolation: Market Overview 4.2 North America: Cell Isolation Market, by Product (2019) 4.3 Geographical Snapshot of the Cell Isolation Market
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing Government Funding for Cell-Based Research 5.2.1.2 Increasing Number of Patients Suffering from Cancer and Infectious Diseases 5.2.1.3 Technological Advancements 5.2.1.4 Growing Focus on Personalized Medicine 5.2.2 Restraints 5.2.2.1 Ethical Issues Related to Embryonic Stem Cell Isolation 5.2.2.2 High Cost of Cell-Based Research 5.2.3 Opportunities 5.2.3.1 Emerging Markets 5.3 COVID-19 Impact on the Cell Isolation/Cell Separation Market
6 Cell Isolation Market, by Product 6.1 Introduction 6.2 Consumables 6.2.1 Reagents, Kits, Media, and Sera 6.2.1.1 Owing to the Disposable Nature of Reagents and Assay Kits, this Market is Driven by Their Consistent Usage and Frequent Purchases 6.2.2 Beads 6.2.2.1 Growing Demand for Magnetic Beads in T-Cell and Stem Cell Isolation is a Major Factor Driving Growth in this Product Segment 6.2.3 Disposables 6.2.3.1 Increasing Investments in Research by Governments and Companies are a Major Factor Boosting the Growth of the Cell Isolation Disposables Market 6.3 Instruments 6.3.1 Centrifuges 6.3.1.1 Growing Use of Centrifuges in the Pharma-Biotech Industry and Multi-Functionality Options Offered by These Instruments are Driving the Growth of this Product Segment 6.3.2 Flow Cytometers 6.3.2.1 Launch of Innovative and Cost-Effective Flow Cytometers is Likely to Drive the Growth of the Market 6.3.3 Magnetic-Activated Cell Separator Systems 6.3.4 Filtration Systems 6.3.4.1 Increasing Research Activities in Cell Biology to Boost the Market
7 Cell Isolation Market, by Cell Type 7.1 Introduction 7.2 Human Cells 7.2.1 Differentiated Cells 7.2.1.1 Growing Investments by Market Players to Develop New and Innovative Products is Expected to Support the Growth of the Differentiated Cell Isolation Market 7.2.2 Stem Cells 7.2.2.1 Rising Government Initiatives Focused on Supporting Stem Cell Research Expected to Drive Market Growth 7.3 Animal Cells 7.3.1 Biopharmaceutical Companies are the Major End-users of Isolated Animal Cells
8 Cell Isolation Market, by Cell Source 8.1 Introduction 8.2 Bone Marrow 8.2.1 a Number of Bone Marrow-Derived Stem Cells Have Been Commercialized in the Last Decade 8.3 Adipose Tissue 8.3.1 Adipose Stem/Stromal Cells Can Generate a Variety of Other Cell Types 8.4 Cord Blood/Embryonic Stem Cells 8.4.1 Market Growth is Driven by the High Therapeutic Potency of These Stem Cells
9 Cell Isolation Market, by Technique 9.1 Introduction 9.2 Centrifugation-Based Cell Isolation 9.2.1 Cost-Effectiveness of this Technique in Both Small-Scale and Large-Scale Operations - A Major Driver 9.3 Surface Marker-Based Cell Isolation 9.3.1 Wide Usage of this Technique in Biopharmaceutical and Biotech Industries is a Major Reason for the Growth of this Market 9.4 Filtration-Based Cell Isolation 9.4.1 The Major Factor Driving the Growth of this Market Segment is the Low Cost of the Filtration Technique
10 Cell Isolation Market, by Application 10.1 Introduction 10.2 Biomolecule Isolation 10.2.1 Biomolecule Isolation Dominates the Cell Isolation Applications Market 10.3 Cancer Research 10.3.1 High Disease Incidence Has Fuelled the Demand for Advanced Treatment 10.4 Stem Cell Research 10.4.1 Increasing Funding in Stem Cell Research to Support Market Growth 10.5 Tissue Regeneration & Regenerative Medicine 10.5.1 Funding for Regenerative Medicine Initiatives Has Risen 10.6 in Vitro Diagnostics 10.6.1 Rising Disease Incidence Has Driven Demand for Innovative Therapies and Diagnostics
11 Cell Isolation Market, by End-user 11.1 Introduction 11.2 Biotechnology & Biopharmaceutical Companies 11.2.1 Favorable Investments Have Boosted Overall Pace of Research 11.3 Research Laboratories & Institutes 11.3.1 Rising Funding for Cell-Based Research to Drive Market Growth 11.4 Hospitals & Diagnostic Laboratories 11.4.1 Increasing Number of Hospitals in Emerging Countries Will Contribute to Market Growth 11.5 Other End-users
12 Cell Isolation Market, by Region 12.1 Introduction 12.2 North America 12.3 Europe 12.4 Asia-Pacific 12.5 Row
13 Competitive Landscape 13.1 Overview 13.2 Market Ranking Analysis, 2019 13.3 Key Strategies 13.3.1 Product Launches, 2017-2020 13.3.2 Expansions, 2017-2020 13.3.3 Partnerships, 2017-2020 13.3.4 Acquisitions, 2017-2020 13.4 Competitive Leadership Mapping (2019) 13.4.1 Stars 13.4.2 Emerging Leaders 13.4.3 Pervasive Players 13.4.4 Participants
14 Company Profiles 14.1 Thermo Fisher Scientific, Inc. 14.2 Becton, Dickinson and Company 14.3 Beckman Coulter Inc. (Subsidiary of Danaher Corporation) 14.4 Merck KGaA 14.5 Terumo Bct (Subsidiary of Terumo Corporation) 14.6 GE Healthcare 14.7 Bio-Rad Laboratories, Inc. 14.8 Corning Incorporation 14.9 Roche Diagnostics (A Division of F. Hoffman-La Roche Ltd.) 14.10 Alfa Laval 14.11 Miltenyi Biotec 14.12 Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. Kg 14.13 Stemcell Technologies, Inc. 14.14 Akadeum Life Sciences 14.15 Bio-Techne 14.16 Biolegend 14.17 Biolegend
15 Appendix 15.1 Insights of Industry Experts 15.2 Discussion Guide
For more information about this report visit https://www.researchandmarkets.com/r/7h0fcv
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets Laura Wood, Senior Manager [emailprotected]
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
http://www.researchandmarkets.com
Go here to see the original:
The Worldwide Cell Isolation/Cell Separation Industry is Expected to Grow at a CAGR of 16.8% Between 2020 to 2025 - PRNewswire
- Mouth Sores from Chemo: Symptoms, Causes, and Treatments - Healthline - February 19th, 2021
- ThermoGenesis Holdings Begins a Year of Celebration of its 35th Anniversary in the Cell Banking and Cell Therapy Industry - PRNewswire - February 19th, 2021
- Meet the women hoping to recruit more stem cells donors from Black communities - CTV News - February 19th, 2021
- CAR T-Cell Therapy Carves Out a Role in Multiple Myeloma - OncLive - February 19th, 2021
- AI project to power the future of stem cell manufacturing - TechCentral.ie - February 17th, 2021
- Promising Results for Stem Cell Treatment of Degenerative ... - February 14th, 2021
- Stem Cell Therapy for Heart Disease - Cleveland Clinic - February 14th, 2021
- Stem Cell Therapy for Stroke Recovery | University of ... - February 14th, 2021
- Stem Cell Treatment: Future of Modern Medicine | Science Times - February 14th, 2021
- Researchers may have found a miracle cure for baldness - BGR - February 14th, 2021
- Types of leukemia: Prevalence, treatment options, and prognosis - Medical News Today - February 14th, 2021
- Jasper Therapeutics Announces Launch of New Clinical Trial with National Heart, Lung, and Blood Institute to Evaluate JSP191 in Sickle Cell Disease -... - February 14th, 2021
- Global Stem Cell Therapy Market Set to Reach USD 214.5 Million by 2024 - The Courier - February 14th, 2021
- Keep it Flowing: Combating COVID-19 Blood Shortages in Cancer Treatment - Curetoday.com - February 14th, 2021
- Network-based screen in iPSC-derived cells reveals therapeutic candidate for heart valve disease - Science - February 14th, 2021
- AlloVir Research Presented at the 2021 Transplantation & Cellular Therapy Meeting Digital Experience - Business Wire - February 14th, 2021
- Orchard Therapeutics talks the benefits of HSC therapy - BioProcess Insider - February 14th, 2021
- Protein Discovery in the Development of New Hearing Hair Cells Could Lead to Treatments for Hearing Loss - SciTechDaily - February 7th, 2021
- Stem cells efficacy confirmed in treating ototoxic hearing loss - Korea Biomedical Review - February 4th, 2021
- Groundbreaking Trial Shows Umbilical-Cord Derived Mesenchymal Stem Cell Infusions Save Lives of Sickest COVID-19 Patients - HospiMedica - January 22nd, 2021
- Massive Growth in Canine Stem Cell Therapy Market Set to Witness Huge Growth by 2027| VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana... - January 22nd, 2021
- Autologous stem cell transplantation versus bortezomib for the first line treatment of systemic light chain amyloidosis in the UK - DocWire News - January 22nd, 2021
- Promising Steps Toward Retinal Cell Transplants to Fight Blindness - HealthDay News - January 22nd, 2021
- Hemostemix Announces the Bread Contract with the Department of Foreign Affairs, Trade & Development Canada - InvestorIntel - January 22nd, 2021
- Trending News on Targeted Oncology, Week of January 22, 2021 - Targeted Oncology - January 22nd, 2021
- Stem Cell Therapy Market Size, Growth Opportunities, Trends, Key Players and Forecast to 2027 - The Courier - January 22nd, 2021
- Time To Book Profit In Fate Therapeutics Stock After A 5x Rally? - Forbes - January 22nd, 2021
- Reid Merryman, MD, on Study Findings Investigating Prognostic Value of ctDNA for Patients with DLBCL - Cancer Network - January 22nd, 2021
- Co-founder Thomas Smeenk on the benefits of Hemostemix autologous stem cell therapy - InvestorIntel - January 12th, 2021
- Covid-19 Impact On Stem Cell Therapy Market 2020 Huge Potential in Future Growth by 2027 | Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc.,... - January 12th, 2021
- Adipose Derived Stem Cell Therapy Market Analysis and Forecast, 2020-2026 Coherent Market Insights | BioRestorative Therapies, Inc., Celltex... - January 12th, 2021
- New COVID-19 Treatment Uses Stem Cells - Freethink - January 12th, 2021
- Creative Medical Technology Holdings Files Investigational New Drug Application (IND) with FDA for Treatment of Stroke using ImmCelz Regenerative... - January 12th, 2021
- Global Cell Freezing Media for Cell Therapy Market 2020 Dynamics Analysis, Size Witness Growth Acceleration During 2025 - KSU | The Sentinel Newspaper - January 12th, 2021
- Gamida Cell to Present Full Data from Phase 3 Study of Omidubicel at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and... - January 12th, 2021
- Cate Dyer of StemExpress is Named Businesswoman of the Year! - PRNewswire - January 12th, 2021
- Adocia Files Patent on a Hydrogel Scaffold for Cell Therapy in the Treatment of Type 1 Diabetes - Business Wire - January 12th, 2021
- Gene Therapy Market Estimated to Record Highest CAGR by 2024 - KSU | The Sentinel Newspaper - January 12th, 2021
- Stem cell treatment corrects skull shape and restores brain function in mouse model of childhood disorder - National Institutes of Health - January 9th, 2021
- Doctors Make Medical Breakthrough In Treating Severe Cases Of COVID - CBS New York - January 9th, 2021
- Global Stem Cell Therapy Market Report 2020: Market to Recover and Reach $14.76 Billion in 2023 at a CAGR of 19.62% - Forecast to 2030 - Yahoo Finance - January 9th, 2021
- Engineered stem cells that evade immune detection could boost cell therapy and I-O - FierceBiotech - January 9th, 2021
- BENEV Announces Investigative Report on Combination Treatment with Human Adipose Tissue Stem Cell- derived Exosomes and Fractional CO2 Laser for Acne... - January 9th, 2021
- Four promising COVID-19 therapies being tested at nearby UVA - Rappahannock News - January 9th, 2021
- MCL Landscape Adapts to Changes After CAR T-Cell Therapy Approval - OncLive - January 9th, 2021
- Regenerative Medicine Market to Reach Valuation US$ 23.7 Bn by 2027 - GlobeNewswire - January 9th, 2021
- Unlocking The Unlimited Potential Of Stem Cells - CodeBlue - January 9th, 2021
- Stem Cell Treatment Proving Highly Successful In Treating Most Severe Cases Of COVID - Yahoo News - January 9th, 2021
- Factor Bioscience spins out a new cell therapy player with eyes on the clinic within 2 years - Endpoints News - January 9th, 2021
- Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in... - January 9th, 2021
- Top 10 ALS Stories of 2020 - ALS News Today - January 9th, 2021
- Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy - BioSpace - January 9th, 2021
- Results Show Promising Efficacy in MCL With Next-Generation BTK Inhibitor LOXO-305 - Cancer Network - January 9th, 2021
- BlueRock Therapeutics in Collaboration with Memorial Sloan Kettering Cancer Center Receives IND Clearance for DA01 in Parkinson's Disease - BioSpace - January 9th, 2021
- Stem Cell Therapy Market Size, Share & Trends Analysis Report By Product Types, And Applications Forecast To 2026 - Farming Sector - January 5th, 2021
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2027 - LionLowdown - January 5th, 2021
- Stem Cell Therapy Market Analysis, COVID-19 Impact,Outlook, Opportunities, Size, Share Forecast and Supply Demand 2021-2025 - Farming Sector - January 5th, 2021
- AGC Biologics Confirms Cell and Gene Therapy Commercial Expertise as Manufacturer of Orchard Therapeutics' Newly Approved Libmeldy - PRNewswire - January 5th, 2021
- Forge Biologics Announces FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Trial (RESKUE) of FBX-101 Gene Therapy for... - January 5th, 2021
- MorphoSys and Incyte Announce the Acceptance of the Swissmedic Marketing Authorization Application f - PharmiWeb.com - January 5th, 2021
- Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in... - January 5th, 2021
- Global Circulating Tumor Cells and Cancer Stem Cells Market To Reach A New Threshold of Growth By 2026 - The Courier - January 5th, 2021
- Catheters Market: Europe and North America Emerge as Leading Regional Market with Well-established Healthcare Infrastructure - BioSpace - January 5th, 2021
- Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemiatargeted imaging and therapy - Science Advances - January 5th, 2021
- Global Cell Therapy Market Report 2020: Market to Recover in 2023 - PRNewswire - January 3rd, 2021
- Lonza's Cocoon will soon make dozens of stem cell therapies all at once - Innovation Origins - January 3rd, 2021
- Induced Pluripotent Stem Cell Derived Human Lung Organoids to Map and Treat the SARS-CoV2 Infections In Vitro - DocWire News - January 3rd, 2021
- Creative Medical Technology Holdings Announces Patent filing based on Preclinical Data in Model of Heart Attack using ImmCelz Regenerative... - January 3rd, 2021
- Haywards Heath carer trying to raise funds for MS treatment - The Argus - January 3rd, 2021
- Chronic graft-versus-host disease in children and adolescents with thalassemia after hematopoietic stem cell transplantation - DocWire News - January 3rd, 2021
- COVID-19-positive cancer patients undergoing active anticancer treatment: An analysis of clinical features and outcomes - DocWire News - January 3rd, 2021
- Cell Therapy Market 2020-2026 by Growth, Demand and Upcoming Business Opportunities - Farming Sector - January 3rd, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market Latest Trends and Future Growth Study by 2029 - Farming Sector - December 31st, 2020
- Creative Medical Technology Holdings Announces Reversion of Liver Failure Using ImmCelz Personalized Cellular Immunotherapy in Preclinical Model -... - December 31st, 2020
- Impacts of COVID 19 on Stem Cell Therapy Market 2020 Size, Demand, Opportunities & Forecast To 2026 - Factory Gate - December 31st, 2020
- Efficacy and safety of mesenchymal stem cells for the treatment of patients infected with COVID-19: a systematic review and meta-analysis protocol -... - December 31st, 2020
- Global Stem Cell Therapy Market Industry 2021 In-depth Market Analysis and Recent Developments, Share, Revenue and Forecast 2025 | Anterogen Co. Inc.... - December 31st, 2020
- Nociceptive neurons shown to boost hematopoiesis | 2020-12-28 - BioWorld Online - December 28th, 2020
- Stem Cell Therapy Market 2020: Demand Analysis, Key Players, Trends, Sales, Supply, Deployment Model, Segments, Organization Size, Production, Revenue... - December 28th, 2020
- Stem Cell Therapy Market (COVID-19 Analysis) 2020-2025 Is Booming Worldwide with Comprehensive Study Explores Huge Revenue Scope in Future - Farming... - December 28th, 2020